Latest Breaking News On - நிறுவனம் க்கு ஒருங்கிணைந்த பொருளாதார ஆராய்ச்சி - Page 1 : comparemela.com

A vaxxing problem: why aren’t more Australian companies producing vaccines? We’re sorry, this service is currently unavailable. Please try again later. Dismiss Normal text size Very large text size In Melbourne, a manufacturing facility that could potentially be repurposed to help produce a COVID-19 vaccine sits idle. The facility – owned by pharmaceutical company IDT Australia – was opened in 2008 by then-premier John Brumby, and among the types of products made on its production line were antibiotics. But the facility fell into disuse as it became cheaper to manufacture medicines offshore. In March, the federal Health Department asked IDT to conduct a feasibility assessment to determine if its facility could be used “to supplement the production capacity for a COVID-19 vaccine”. The answer was yes. IDT facilities could be used to produce a vaccine, including an mRNA vaccine.

New yorkUnited statesSouth australiaNew south walesUnited kingdomPapua new guineaDavid sparlingWayne taylorJohn brumbyJoe bidenColin poutonMonash university institute of pharmaceutical sciencesEuropean commissionInstitute for integrated economic researchNew york timesHealth department